Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

Bayer announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's new drug application (NDA) and granted Priority Review designation for the investigational compound ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

The Food and Drug Administration has rejected an application filed by Langhorne-based Savara for its new drug candidate ...

In mice, the combination therapy not only improved the health of aging mice, but also extended their lifespan by around 30 ...

The FDA cleared an investigational new drug application for AVZO-1418/DB-1418, and a phase 1/2 trial in advanced solid tumors ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing ...

Proposition 36, a law passed in California to toughen penalties for theft and drug offenses, has resulted in over 160 felony ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...

Overview - - The U.S. Food and Drug Administration (FDA) announced that it aims to increase the agency’s use of artificial intelligence (AI) ...